- Home
- ZGN vs AAPG Comparison
ZGN vs AAPG Comparison
Compare ZGN & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- AAPG
- Stock Information
- Founded
- ZGN 1910
- AAPG 2009
- Country
- ZGN Italy
- AAPG China
- Employees
- ZGN N/A
- AAPG N/A
- Industry
- ZGN Apparel
- AAPG Biotechnology: Pharmaceutical Preparations
- Sector
- ZGN Consumer Discretionary
- AAPG Health Care
- Exchange
- ZGN Nasdaq
- AAPG Nasdaq
- Market Cap
- ZGN 1.9B
- AAPG 1.7B
- IPO Year
- ZGN N/A
- AAPG 2025
- Fundamental
- Price
- ZGN $6.68
- AAPG $21.41
- Analyst Decision
- ZGN Buy
- AAPG Buy
- Analyst Count
- ZGN 2
- AAPG 1
- Target Price
- ZGN $8.05
- AAPG N/A
- AVG Volume (30 Days)
- ZGN 937.3K
- AAPG 30.2K
- Earning Date
- ZGN 03-27-2025
- AAPG 05-06-2025
- Dividend Yield
- ZGN 1.96%
- AAPG N/A
- EPS Growth
- ZGN N/A
- AAPG N/A
- EPS
- ZGN 0.31
- AAPG N/A
- Revenue
- ZGN $2,015,371,157.00
- AAPG $134,352,180.00
- Revenue This Year
- ZGN $4.49
- AAPG N/A
- Revenue Next Year
- ZGN $5.90
- AAPG $386.68
- P/E Ratio
- ZGN $21.14
- AAPG N/A
- Revenue Growth
- ZGN 2.21
- AAPG 341.77
- 52 Week Low
- ZGN $6.39
- AAPG $16.50
- 52 Week High
- ZGN $14.17
- AAPG $24.02
- Technical
- Relative Strength Index (RSI)
- ZGN 26.65
- AAPG N/A
- Support Level
- ZGN $7.07
- AAPG N/A
- Resistance Level
- ZGN $8.10
- AAPG N/A
- Average True Range (ATR)
- ZGN 0.32
- AAPG 0.00
- MACD
- ZGN -0.05
- AAPG 0.00
- Stochastic Oscillator
- ZGN 6.44
- AAPG 0.00
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.